HUP9802889A2 - Tulobuterolt tartalmazó perkután készítmények - Google Patents

Tulobuterolt tartalmazó perkután készítmények

Info

Publication number
HUP9802889A2
HUP9802889A2 HU9802889A HUP9802889A HUP9802889A2 HU P9802889 A2 HUP9802889 A2 HU P9802889A2 HU 9802889 A HU9802889 A HU 9802889A HU P9802889 A HUP9802889 A HU P9802889A HU P9802889 A2 HUP9802889 A2 HU P9802889A2
Authority
HU
Hungary
Prior art keywords
needle
patch layer
tulobuterol
time
percutaneous preparations
Prior art date
Application number
HU9802889A
Other languages
English (en)
Inventor
Mitsuhiko Hori
Yoshihisa Nakano
Saburo Otsuka
Keiji Yamamoto
Original Assignee
Hokuriku Seiyaku Co. Ltd.
Nitto Denko Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Seiyaku Co. Ltd., Nitto Denko Corporation filed Critical Hokuriku Seiyaku Co. Ltd.
Publication of HU9802889D0 publication Critical patent/HU9802889D0/hu
Publication of HUP9802889A2 publication Critical patent/HUP9802889A2/hu
Publication of HUP9802889A3 publication Critical patent/HUP9802889A3/hu
Publication of HU227974B1 publication Critical patent/HU227974B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Perkűtán abszőrpciós típűsú készítmény, azzal jellemezve, hőgy egyalapőt és egy erre rétegelt tapaszréteget tartalmaz, ez űtóbbibanragasztó mellett nem kevesebb, mint 5 tömeg% őldőtt tűlőbűteről van. Ajelen találmány készítménye az aktív alkőtórészt, a tűlőbűterőlt, nagykőncentrációban a tapaszrétegben teljesen felőldőtt állapőtbanmegőrzi. Ezért, az idő előrehaladtával a gyógyszerkristályőkkicsapódása által őkőzőtt gyógyszer-kibőcsátási sajátősságtól és azadhéziós tűlajdőnság időbeli lefőlyásának váltőzásaitól mentes. ŕ
HU9802889A 1997-12-12 1998-12-11 Percutaneous preparations comprising tulobuterol HU227974B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34258297 1997-12-12
JP30449898A JP3930984B2 (ja) 1997-12-12 1998-10-26 経皮吸収型製剤

Publications (4)

Publication Number Publication Date
HU9802889D0 HU9802889D0 (en) 1999-02-01
HUP9802889A2 true HUP9802889A2 (hu) 1999-06-28
HUP9802889A3 HUP9802889A3 (en) 2001-04-28
HU227974B1 HU227974B1 (en) 2012-07-30

Family

ID=26563935

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802889A HU227974B1 (en) 1997-12-12 1998-12-11 Percutaneous preparations comprising tulobuterol

Country Status (15)

Country Link
US (1) US6117447A (hu)
EP (1) EP0922453B1 (hu)
JP (1) JP3930984B2 (hu)
KR (1) KR100610185B1 (hu)
CN (1) CN1129426C (hu)
AT (1) ATE305775T1 (hu)
BR (1) BR9806470B1 (hu)
CA (1) CA2255447C (hu)
DE (1) DE69831785T2 (hu)
DK (1) DK0922453T3 (hu)
ES (1) ES2246062T3 (hu)
HK (1) HK1022091A1 (hu)
HU (1) HU227974B1 (hu)
PL (1) PL194195B1 (hu)
PT (1) PT922453E (hu)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3930984B2 (ja) * 1997-12-12 2007-06-13 日東電工株式会社 経皮吸収型製剤
DE19950066A1 (de) * 1999-10-16 2001-04-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut
JP3711846B2 (ja) * 2000-07-27 2005-11-02 株式会社村田製作所 高周波モジュール及びそれを用いた移動体通信装置
DE60039726D1 (de) * 2000-12-29 2008-09-11 Martin Francis Gannon Tiernahrungsmittelzusammensetzung
KR100439659B1 (ko) * 2001-06-23 2004-07-12 제일약품주식회사 툴로부테롤을 함유하는 경피흡수용 패취제
KR100535302B1 (ko) * 2002-02-01 2005-12-08 주식회사 태평양 툴로부테롤 함유 경피흡수형 제제
KR100469995B1 (ko) * 2002-05-20 2005-02-05 안국약품 주식회사 천식치료제를 함유한 매트릭스형 패취
JP2004224701A (ja) * 2003-01-17 2004-08-12 Yuutoku Yakuhin Kogyo Kk 外用貼付剤
JP2004224741A (ja) * 2003-01-23 2004-08-12 Hisamitsu Pharmaceut Co Inc ツロブテロール経皮吸収型製剤
JP4617069B2 (ja) * 2003-06-16 2011-01-19 コスメディ製薬株式会社 貼付剤
WO2004112770A1 (ja) 2003-06-20 2004-12-29 Teikoku Seiyaku Co., Ltd. ツロブテロール含有貼付剤
EP1685830A4 (en) * 2003-11-21 2010-04-28 Sekisui Chemical Co Ltd PLASTER
CN1297257C (zh) * 2004-01-02 2007-01-31 上海现代药物制剂工程研究中心有限公司 含有妥洛特罗的压敏胶，透皮贴剂及制备方法和应用
WO2005067910A1 (ja) * 2004-01-20 2005-07-28 Saitama Daiichi Pharmaceutical Co., Ltd. ツロブテロール貼付剤
KR100579721B1 (ko) 2004-09-15 2006-05-15 (주) 에프디엘 툴로부테롤을 함유하는 경피투여용 패취제
JP2006206471A (ja) * 2005-01-26 2006-08-10 Nitto Denko Corp テープ製剤
US7700659B2 (en) 2005-03-24 2010-04-20 Advanced Cardiovascular Systems, Inc. Implantable devices formed of non-fouling methacrylate or acrylate polymers
US9381279B2 (en) 2005-03-24 2016-07-05 Abbott Cardiovascular Systems Inc. Implantable devices formed on non-fouling methacrylate or acrylate polymers
JP5058531B2 (ja) * 2005-09-09 2012-10-24 日東電工株式会社 ビソプロロール含有貼付製剤
JP4945228B2 (ja) 2005-12-13 2012-06-06 日東電工株式会社 ビソプロロール含有貼付製剤
AU2008221861B2 (en) * 2007-03-08 2013-03-21 Nitto Denko Corporation Device for the transdermal administration of bisoprolol
KR100956023B1 (ko) * 2007-09-28 2010-05-06 대화제약 주식회사 산성 관능기를 갖는 아크릴레이트계 고분자의 함량으로약물 방출속도를 제어하는 툴로부테롤 경피 투여용 패취제
JP2009286707A (ja) * 2008-05-27 2009-12-10 Nitto Denko Corp 医療材料又は衛生材料用のゲル組成物、その成形体及びそれを用いた貼付材もしくは貼付製剤
JP5432614B2 (ja) 2008-07-17 2014-03-05 日東電工株式会社 貼付剤および貼付製剤
JP5432613B2 (ja) * 2008-07-17 2014-03-05 日東電工株式会社 貼付剤および貼付製剤
JP2010241746A (ja) * 2009-04-07 2010-10-28 Nitto Denko Corp 貼付剤および貼付製剤
JP5404145B2 (ja) * 2009-04-10 2014-01-29 日東電工株式会社 貼付剤および貼付製剤
JP5766475B2 (ja) * 2010-03-30 2015-08-19 日東電工株式会社 貼付製剤およびその製造方法
EP2667861A4 (en) * 2011-01-26 2014-07-16 Csi Gmbh TRANSDERMAL PROLONGED RELEASE PATCHES ASSOCIATING A BETA-AGONIST AND ANTICHOLINERGIC AND METHODS OF USE
WO2012103015A2 (en) * 2011-01-27 2012-08-02 Csi Gmbh Extended-release beta agonist/steroid transdermal patches and methods for using the same
CN103127032A (zh) * 2011-11-30 2013-06-05 大化制药株式会社 妥洛特罗贴剂
JP6757351B2 (ja) 2017-04-28 2020-09-16 日東電工株式会社 経皮吸収型製剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5300291A (en) * 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
JPH0725669B2 (ja) * 1988-12-23 1995-03-22 日東電工株式会社 経皮投与用医薬製剤
DE4002281A1 (de) * 1990-01-26 1991-08-01 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit dem wirkstoff tulobuterol
IT1251469B (it) * 1991-07-15 1995-05-15 Zambon Spa Sistema terapeutico transdermale per la somministrazione di farmaci ad attivita' broncodilatante.
JP2753800B2 (ja) * 1994-04-14 1998-05-20 日東電工株式会社 経皮吸収型製剤
JP3604177B2 (ja) * 1994-09-14 2004-12-22 日東電工株式会社 経皮吸収製剤
JPH08295624A (ja) * 1995-04-26 1996-11-12 Read Chem Kk プラスター基剤、その製造方法、該基剤を使用した外用貼 付剤
JP3930984B2 (ja) * 1997-12-12 2007-06-13 日東電工株式会社 経皮吸収型製剤

Also Published As

Publication number Publication date
KR100610185B1 (ko) 2006-11-30
US6117447A (en) 2000-09-12
JP3930984B2 (ja) 2007-06-13
PL330212A1 (en) 1999-06-21
HU9802889D0 (en) 1999-02-01
PL194195B1 (pl) 2007-05-31
DK0922453T3 (da) 2005-11-07
KR19990062986A (ko) 1999-07-26
DE69831785T2 (de) 2006-07-13
HU227974B1 (en) 2012-07-30
ATE305775T1 (de) 2005-10-15
EP0922453A3 (en) 1999-11-24
EP0922453A2 (en) 1999-06-16
HK1022091A1 (en) 2000-07-28
ES2246062T3 (es) 2006-02-01
CN1226422A (zh) 1999-08-25
EP0922453B1 (en) 2005-10-05
PT922453E (pt) 2005-11-30
CA2255447A1 (en) 1999-06-12
BR9806470B1 (pt) 2012-03-20
CA2255447C (en) 2006-01-24
BR9806470A (pt) 2000-04-11
CN1129426C (zh) 2003-12-03
JPH11228395A (ja) 1999-08-24
HUP9802889A3 (en) 2001-04-28
DE69831785D1 (de) 2006-02-16

Similar Documents

Publication Publication Date Title
HUP9802889A2 (hu) Tulobuterolt tartalmazó perkután készítmények
WO1995001167A3 (en) Incorporating poly-n-vinyl amide in a transdermal system
HUP0101512A2 (hu) Adhéziós mikrogyöngy hatóanyag-adagoló készítmény, eljárás az előállítására és a készítményt tartalmazó eszköz
HUP9802287A2 (hu) Cinkkel és kívánt esetben lizinnel vagy kalciumionnal előkezelt növekedési hormont tartalmazó stabilizált gyógyszerkészítmény
DE60018100D1 (en) Polymorphe form von atorvastatin-calcium
WO2002036732A3 (en) Active variants of fgf with improved specificity
BR9808933A (pt) Composição sob forma de microcápsulas ou de implantes, processo de preparação de uma substância hidrossolúvel, substância ativa, acetato de triptorelina, acetato de lanreotìdeo, ou acetato de octreotìdeo, e rna de filamento duplo
DE69710557D1 (de) Zinc, Kupferverbindung und Aminosäure enthaltende Zusammensetzung zur oralen Verabreichung
ATE223745T1 (de) Zusammensetzung zur verbesserten elektroübertragunslieferung von wirkstoff
WO2003018075A3 (de) Transdermales therapeutisches system mit fentanyl bzw. verwandten substanzen
MX9500159A (es) Preparacion farmaceutica percutanea.
CA2366932A1 (en) Cyclic protein tyrosine kinase inhibitors
BR0212052A (pt) Preparação de composição farmacêutica de liberação prolongada
TR200100812T2 (tr) Akut ağrı tedavisi için fentanil kompozisyon.
TR199901250T2 (xx) Tedavi ama�l� ajanlar.
AU4710499A (en) Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use ofsuch compounds
WO2001021589A3 (en) Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof
EP0934748A3 (en) Von Willenbrand factor (vWF)- containing preparation, process for preparing vWF-containing preparations, and use of such preparations
WO2004056347A3 (en) Pharmaceutical compositions comprising insulin and legends of insulin hexamer
WO2001078682A3 (en) Sustained release drug compositions
BR0307048A (pt) Composição farmacêutica orodispersìvel de perindoprila
BRPI0417530B8 (pt) composição para a liberação transdérmica de hormônios sem a necessidade de melhoradores de penetração, sistema terapêutico transdérmico, e kit
AU1041397A (en) Antigenic protein originating in malassezia
WO2002028424A3 (en) Kyberdrug as autovaccines with immune-regulating effects
DE59811656D1 (en) Kombinationspräparat aus 2-methylthiazolidin-2,4-dicarbonsäure und paracetamol

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees